Introduction {#sec1-1}
============

*Salmonella* species were discovered more than a century ago by Salmon, an American scientist. They are Gram-negative, motile, facultative anaerobic bacteria and classified within the Enterobacteriaceae family \[[@ref1]\]. *Salmonella* are regarded as a major food-borne pathogen that causes an economic burden for health care systems worldwide \[[@ref2]\]. The consumption of animal products contaminated with *Salmonella* is the leading cause of human Salmonellosis \[[@ref3]\]. Globally, 94 million cases of gastroenteritis were caused by *Salmonella* with 155,000 deaths each year, knowing that 85% of them were related to food \[[@ref4]\]. In the United States, a study estimated that nontyphoidal *Salmonella* were responsible for 1,027,000 cases of food-borne illness each year, with 19,586 hospitalizations and 378 deaths \[[@ref5]\]. In Morocco, *Salmonella* are responsible for 42.8% of food-borne diseases \[[@ref6]\].

The pathogenicity of *Salmonella* is influenced by a variety of virulence factors that play an important role in a wide range of pathogenic mechanisms, such as adhesion, invasion, intracellular survival, toxin production, and iron acquisition \[[@ref7]\]. However, the presence of virulence genes in multidrug-resistant strains of *Salmonella* is associated with a severe infection and is a major public health concern \[[@ref8]\].

The identification of *Salmonella* is subjected to various constraints due to the greater diversity of its species and serovars. The *Salmonella* genus contains two species, *Salmonella bongori* and *Salmonella enterica*, which is divided into six subspecies with the presence of more than 2600 serotypes \[[@ref9]\]. Nowadays, it is agreed that the identification of *Salmonella* by biochemical and serological techniques requires about a week \[[@ref10]\]. Hence, molecular methods based on DNA sequences represent the best alternatives for accurate and rapid bacterial identifications.

In the last years, the use of DNA sequencing has increased in the determination of the evolutionary relationships of different bacteria \[[@ref11], [@ref12]\]. In relation to *Salmonella*, phylogenetic studies includes sequencing of 16S rRNA, 23S rRNA, housekeeping genes, virulence genes, and *inv-spa* invasion gene complex \[[@ref12]\]. It has been shown that genetic analysis of 16S rRNA gene increases the resolution between genus and species of *Salmonella enterica* and has a major role in bacterial phylogeny and taxonomic studies \[[@ref13]\].

In Africa, specifically in Morocco, we noticed a lack of information for *Salmonella* pathogenicity and molecular identification. Thus, in this context, the objectives of this study were (i) to analyze the 16S rRNA sequences of 34 *Salmonella* strains isolated from sausages and determine their phylogenetic relationship, (ii) to study the distribution of 6 virulence genes among the isolated strains, and (iii) to assess their antimicrobial resistance using 26 antibiotics.

Materials and Methods {#sec1-2}
=====================

Isolation, Identification and Antimicrobial Susceptibility Testing {#sec2-1}
------------------------------------------------------------------

Thirty four *Salmonella enterica* belonging to 12 serotypes were isolated from sausages (beef sausages, turkey sausages, and artisanal sausages "merguez") sold in Meknes city in Morocco and confirmed by biochemical, serological, and molecular tests \[[@ref10]\]. The disc diffusion method on Mueller--Hinton agar was used to study the antimicrobial susceptibility profiles of isolated *Salmonella* against 26 antibiotics ([Table 1](#table001){ref-type="table"}). Results were interpreted according to the recommendation of the Clinical and Laboratory Standards Institute \[[@ref14]\]. *E. coli* ATCC 25922 was used as a positive control of this study, and the isolated *Salmonella* strains showing a decrease in susceptibility (intermediate) were considered as resistant.

Amplification of the Virulence Genes Using Multiplex Polymerase Chain Reaction (PCR) {#sec2-2}
------------------------------------------------------------------------------------

Simplex and multiplex PCR methods were used to examine the presence of 6 virulence genes in the isolated *Salmonella* ([Table 2](#table002){ref-type="table"}), using their gene specific primers as described in [Table 3](#table003){ref-type="table"}. The simplex PCR method was used to amplify the genes *spiA, iroN*, and *sifA* as described previously by Mezal et al. \[[@ref15]\]. Meanwhile, the multiplex PCR method was used to amplify the genes *orgA, sipB*, and *sitC* as described by Skyberg et al. \[[@ref7]\]. The amplification was done in a Mastercycler gradient (Perkin-Elmer, Boston, MA) under the following conditions: 5 min at 95 °C, 30 cycles of 30 s at 94 °C, 30 s at 66.5°C, and 2 min at 72 °C, with a final cycle of 10 min at 72 °C. The isolated strains were considered positive for the tested virulence genes if they produce an amplicon with the expected size ([Table 3](#table003){ref-type="table"}). *Salmonella enterica* serovar typhimurium DT104 was used as positive control.

Amplification and Sequencing of the 16S rRNA Genes {#sec2-3}
--------------------------------------------------

DNA was extracted from a culture on liquid medium using DNA Isolation Kit (Gen Elute Bacterial Genomic DNA kit, Sigma) according to the manufacturer\'s instructions. The amplification of 16S rRNA gene was performed in a reaction mixture of 25 μL, with 12.5 μL of ddH~2~O, 2.5 μL of 10*x* PCR buffer, 3.0 μL of 50 mM MgCl~2~, 0.5 μL of 10mM dNTPs (KAPA Biosystems, USA), 2 μL of template DNA (70 ng/μL), 0.2 μL of Taq DNA polymerase enzyme (5 U/μL; KAPA Biosystems, USA), and 1.25 μL of 10 μM from each primer: fD~1~ (AGAGTTTGATCCTGGCTCAG) and rP~2~ (ACGGCTACCTTGTTACGACTT) \[[@ref16]\]. The amplification was performed in "Veriti" thermal cycler (Applied Biosystems, USA) under the following conditions: 10 min at 94 °C, 36 cycles of 1 min at 94 °C, 30 s at 52 °C, 2 min at 72 °C, and a final cycle of 10 min at 72 °C. Electrophoresis migration was done in 1% agarose (Sigma) for 1 h at 100 V. Then, gel was stained in ethidium bromide with a concentration of 0 .5 μg/mL for 20 min, rinsed, and visualized using «G Box» system (Applied Biosystems, USA).

The obtained PCR products were purified by QIAquick PCR purification kit (ExoSAP-IT Affymetrix, USA), and sequenced bi-directionally using Big Dye Terminator Kit version 3.1 (Applied Biosystems) to prepare sequencing reactions. The sequencing procedure was conducted by 3130 XL Genetic Analyzer according to the manufacturer\'s instructions (Applied Biosystems, USA). Then, the collected data were analyzed by data collection software version 3.0 and sequencing analysis software version 5.3.1 (Applied Biosystems, USA). The sequences were manually trimmed and analyzed with the Basic Local Alignment Search Tool (BLAST).

Phylogenetic Analysis {#sec2-4}
---------------------

The sequences were aligned with ClustalW, the evolutionary history was inferred using the neighbor-joining method, and the evolutionary distances were computed using the maximum composite likelihood method (Mega7 software) with 1000 bootstrap replications. *Salmonella enterica* str. 08-00436, *Salmonella* Mbandaka str. SA20026234, *Salmonella* Agona str. 460004 2-1, and *Salmonella* Typhi str. CT18 were used as in-group strains, and *Escherichia coli* ATCC 8739 was used as an out-group strain to root the phylogenetic tree.

Ethics {#sec2-5}
------

Ethical approval was not required in this study since no live animals or humans samples were used in the experiments.

Results {#sec1-3}
=======

Isolation, Identification and Antimicrobial Susceptibility Testing {#sec2-6}
------------------------------------------------------------------

Among the 34 isolated *Salmonella*, 12 serotypes were identified ([Table 4](#table004){ref-type="table"}). In addition, the antimicrobial resistance analysis has shown a high rate of resistance to several antibiotics, with presence of 13 different phenotypic profiles ([Table 4](#table004){ref-type="table"}). Moreover, multidrug resistance (more than two antibiotics) was detected in 15 strains (44%). From them, one *Salmonella* typhimurium strain was considered as the highest by exerting resistance against 18 different antimicrobial compounds ([Table 4](#table004){ref-type="table"}).

Amplification of Virulence Genes Using Multiplex PCR {#sec2-7}
----------------------------------------------------

In order to evaluate the pathogenicity of *Salmonella* strains and to have an idea about its capacity to survive in host environments, simplex and multiplex PCR methods were used to detect 6 virulence genes, namely, *orgA, sipB, sitC, spiA, iroN*, and *sifA* ([Figures 1](#fig001){ref-type="fig"} and [2](#fig002){ref-type="fig"}), involved in its virulence system. The results showed that all isolated strains contain the 6 virulence genes ([Table 4](#table004){ref-type="table"}).

Amplification and Sequencing of the 16S rRNA Genes {#sec2-8}
--------------------------------------------------

Amplification of 16S rRNA genes was performed on extracted genomic DNA of isolated *Salmonella* strains. The results showed that all examined strains generate an amplicon of 1500 bp ([Figure 3](#fig003){ref-type="fig"}). Then, PCR products were sequenced and analyzed by the online software "BLAST" (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch), and the obtained sequences were deposited in GenBank under the corresponding accession numbers ([Table 4](#table004){ref-type="table"}).

Phylogenetic Analysis and Identification Criteria {#sec2-9}
-------------------------------------------------

The phylogenetic analysis of 16S rRNA genes organized all the strains into 3 clusters (I, II, and III), and cluster I is divided into 3 sub-clusters (Ia, Ib, and Ic) ([Figure 4](#fig004){ref-type="fig"}). The analysis of 16S rRNA genes groups the serotypes Corvallis, Kentucky, Typhimurium, Anatum, Mbandaka, Livingstone, and Saintpau in cluster I, and cluster II is constituted by S. Montevideo, S. Bovismorbificans, S. Give, and S. Agona. However, cluster III is constituted by 2 strains, namely, S. Muenster and S. Kentucky, which are placed separately on side branches from the strains. Moreover, 16S rRNA based analysis showed that all 16S rRNA sequences possessed a ≥98% similarity to those of *Salmonella enterica* species.

Discussion {#sec1-4}
==========

Worldwide, *Salmonella* are recognized as a major gastrointestinal pathogen for humans and animals, whereas, *Salmonella* typhimurium and *Salmonella* enteritidis were considered as the major serovars that can be infecting human after eating food of animal origin, but this data may be different over the years and countries.

In this study, the antimicrobial resistance analysis revealed the presence of *Salmonella* Kentucky resistant to quinolones and *Salmonella* Typhimurium resistant to multiple antibiotics including 3rd generation cephalosporins. Other studies showed that the resistance to quinolones, fluoroquinolones, and 3rd generation cephalosporins in *Salmonella* has recently increased \[[@ref17]\]. This resistance may be due to the intensive use of antibiotics in the veterinary and human fields by contributing to the acquisition of resistance genes and exerting a selective pressure for the development of resistant bacteria \[[@ref21]\] and may change depending on serotype, time, source of microorganism, and geographic region of isolate \[[@ref22]\].

The pathogenicity of *Salmonella* is influenced by various factors encoded by different virulence genes that play an important role in different steps of pathogenicity, such as adhesion, invasion, intracellular survival, systemic infection, toxin production, and iron acquisition \[[@ref7]\]. In this study, the amplification of virulence genes by PCR showed that all isolated strains contain the 6 tested virulence genes *(orgA, sitC, sipB, spiA, iroN*, and *sifA*).

The host cell invasion and intracellular survival of *Salmonella* depend on several genes that are clustered on pathogenicity islands (PIs), and these effector proteins are transferred by 2 type III secretion systems, namely, T3SS1 and T3SS2 \[[@ref23]\]. Moreover, *Salmonella* strains expresses several invasion genes located on the *Salmonella* pathogenicity islands 1 and 2 (SPI-1 and SPI-2), which promote bacterial uptake and invasion of non-phagocytic cells to cross the epithelial barrier \[[@ref24]\]. Among these genes, *orgA* is required for invasion and secretion system \[[@ref25]\]. Thus, the *sipB* gene is responsible for the entry into non-phagocytic cells and the killing of macrophages. It has been shown that the targeting of *sipB* by the inv-Spa type III secretion apparatus is necessary and sufficient for the induction of macrophage apoptosis \[[@ref26]\].

The *iroN* gene is implicated in iron acquisition \[[@ref27]\]. However, the *sitC* gene encodes an important transporter of iron. Also, a study carried out by Boyer et al. on *Salmonella* Typhimurium showed that *sitABCD* is required for replication of *Salmonella* inside macrophages and for the creation of virulence in susceptible animals \[[@ref28]\]. On the other hand, the *sifA* gene is required for the formation of filamentous structures in the lysosome vacuoles of infected epithelial cells \[[@ref29]\].

A previous study conducted on *Salmonella* typhimurium showed that *spiA* gene codes for an outer membrane component that is essential for virulence in host cells \[[@ref30]\]. Another study carried out by Dong et al. revealed that *spiA* gene is associated with biofilm formation mechanism \[[@ref31]\]. It has been demonstrated that biofilm formation improves the ability of microorganisms to withstand stresses, such as desiccation, temperature extremes, antibiotics, and antiseptics \[[@ref32]\], which allowed these bacteria to survive longer in animal farms and to contaminate meats and eggs, which remain the main vehicles of *Salmonella* transmission to humans.

In Morocco, it is a challenge for laboratories to systematically identify *Salmonella* isolates on the basis of biochemical and serological identification using Kaufmann White scheme because of the cost of reagents and the time needed to get the results. In this study, we conducted a rapid and cost-effective method to identify the isolated *Salmonella* strains using DNA sequencing tools. Furthermore, the sequence analysis of the 16S rRNA genes is being regularly used to identify bacterial species and to perform the taxonomic studies in clinical and scientific investigations \[[@ref33]\]. However, the phylogenetic analyses can be used to understand the emergence of pathogenic bacteria and to study the relationship between isolated strains and other reference strains, implicated in animal or human diseases \[[@ref12], [@ref19], [@ref34]\].

In this study, the analysis of phylogenetic tree showed the presence of different 16S rRNA profiles among the isolated *Salmonella* serovars, which are grouped into 3 clusters and 3 sub-clusters, suggesting the presence of different contamination sources due to the diversity of raw materials and manufacturing processes used for each type of sausages.

Conclusion {#sec1-5}
==========

The results obtained in this study showed that the sequencing of 16S rRNA genes was a suitable tool for identification of *Salmonella* strains at the genus and species level. In addition, the phylogenic analysis showed a high diversity in all clusters of this bacterium. Furthermore, the antimicrobial resistance and the virulence gene analysis suggest that sausages are contaminated with *Salmonella* strains and present a major risk to public health.
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![PCR products amplified with the universal virulence gene primers *(orgA, sipB*, and *sitC).* Lanes: (M) DNA ladder (GeneRuler 1Kb Plus), (1) negative control, (2) positive control, and (3--12) *Salmonella* tested.](eujmi-09-056-g001){#fig001}

![PCR products in agarose gel electrophoresis 1% with the expected molecular size of 550 bp for *SpiA* gene (A), 1205 bp for *IroN* gene (B), and 449 bp for *SifA* gene (C). Lanes: (1--10) *Salmonella* tested, (M) DNA ladder (Hyper Ladder 500 bp), (--) negative control, and (+) positive control](eujmi-09-056-g002){#fig002}

![The amplification results of 16S rRNA genes using universal primers. Lanes: (1) S. Typhimirium, (2) S. Mbandaka, (3) S. Livingstone, (4), S. Muenster, (5) S. Give, (6) S. Bovismorbificans, (7--9) S. Kentucky, (10--11) *S. Corvallis*, (12) S. Montevideo, (13) S. Agona, (14) S. Anatum, (15) S. Saintpaul, and (M) 1Kb DNA ladder](eujmi-09-056-g003){#fig003}

![Phylogenetic tree of isolated *Salmonella enterica* strains based on 16S rRNA sequences analysis using MEGA7](eujmi-09-056-g004){#fig004}

###### 

The antimicrobial agents used in this study

  Antimicrobial agents               Code   Disk Content
  ---------------------------------- ------ ------------------
  Ampicillin                         AMP    10 μg
  Amoxicillin                        AML    25 μg
  Amoxicillin--clavulanic acid       AMC    20 μg/10 μg
  Imipenem                           IPM    10 μg
  Ceftriaxone                        CRO    30 μg
  Cefuroxime sodium                  CXM    30 μg
  Ceftazidime                        CAZ    30 μg
  Cefamandole                        MA     30 μg
  Cefotaxime                         CTX    30 μg
  Cefoxitin                          FOX    30 μg
  Aztreonam                          ATM    30 μg
  *Sulfamethoxazole*                 SMX    200 μg
  Amikacin                           AK     30 μg
  Colistin sulfate                   CT     50 μg
  Kanamycin                          K      30 μg
  Ofloxacin                          OFX    5 μg
  Enrofloxacin                       ENR    5 μg
  Ciprofloxacin                      CIP    5 μg
  *Nalidixic acid*                   NA     30 μg
  *Flumequine*                       UB     30 μg
  Sulfonamide                        SSS    200 μg
  Gentamicin                         CN     30 μg
  Chloramphenicol                    C      30 μg
  Tetracycline                       TE     30 μg
  Streptomycin                       S      10 μg
  Trimethoprim*--sulfamethoxazole*   SXT    1.25 μg/23.75 μg

###### 

Description of genes functions used in this study

  Genes    Virulence-related function                               References
  -------- -------------------------------------------------------- --------------
  *orgA*   Host recognition/invasion                                \[[@ref35]\]
  *sipB*   Entry into nonphagocytic cells, killing of macrophages   \[[@ref36]\]
  *sitC*   Iron acquisition                                         \[[@ref37]\]
  *spiA*   Survival within macrophage                               \[[@ref30]\]
  *iroN*   Iron acquisition                                         \[[@ref27]\]
  *sifA*   Filamentous structure formation                          \[[@ref29]\]

###### 

Primers sequences used to amplify the virulence genes of isolated Salmonella

  -----------------------------------------------------------------------------------------------------------------------------
  Virulence genes   Primer sequence (5′-3′)^*[a](#table3-tfn1){ref-type="table-fn"}*^   Size (bp)   GenBank no.   References
  ----------------- ------------------------------------------------------------------- ----------- ------------- -------------
  *orgA*            F: TTTTTGGCAATGCATCAGGGA\                                           255         NC003197      \[[@ref7]\]
                    R: GGCGAAAGCGGGGACGGTATT                                                                      

  *sitC*            F: CAGTATATGCTCAACGCGATGTGGGTCTCC\                                  768         NC003197      \[[@ref7]\]
                    R: CGGGGCGAAAATAAAGGCTGTGATGAAC                                                               

  *sipB*            F: GGACGCCGCCCGGGAAAAACTCTC\                                        875         NC003197      \[[@ref7]\]
                    R: ACACTCCCGTCGCCGCCTTCACAA                                                                   

  *spiA*            F: CCAGGGGTCGTTAGTGTATTGCGTGAGATG\                                  550         NC003197      \[[@ref7]\]
                    R: CGCGTAACAAAGAACCCGTAGTGATGGATT                                                             

  *iroN*            F: ACTGGCACGGCTCGCTGTCGCTCTAT\                                      1205        NC003197      \[[@ref7]\]
                    R: CGCTTTACCGCCGTTCTGCCACTGC                                                                  

  *sifA*            F: TTTGCCGAACGCGCCCCCACACG\                                         449         NC003197      \[[@ref7]\]
                    R: GTTGCCTTTTCTTGCGCTTTCCACCCATCT                                                             
  -----------------------------------------------------------------------------------------------------------------------------

^*a*^F = forward; R = reverse.

###### 

Virulence genes and antimicrobial resistance profile of *Salmonella* serovars isolated from sausages

  Code    Serotypes          Accession Number   Resistant profiles                                                             Virulence genes                       
  ------- ------------------ ------------------ ------------------------------------------------------------------------------ ----------------- ---- ---- ---- ---- ----
  8D      Agona              KX355299           AMP                                                                            \+                \+   \+   \+   \+   \+
  63 D    Muenster           KX355305           AMP                                                                            \+                \+   \+   \+   \+   \+
  55 MA   Livingstone        KX355303           AMP                                                                            \+                \+   \+   \+   \+   \+
  57 B    Anatum             KX355304           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  3MA     Give               KX355298           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  42MA    Give               MG869141           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  58MA    Give               MG869142           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  29MA    Give               MG869140           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  2B      Bovismorbificans   KX355297           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  12B     Bovismorbificans   MG869128           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  51B     Mbandaka           MG869131           AMP                                                                            \+                \+   \+   \+   \+   \+
  31B     Mbandaka           MG869129           AMP                                                                            \+                \+   \+   \+   \+   \+
  80B     Mbandaka           KX355306           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  9MA     Mbandaka           MG869136           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  17D     Montevideo         KX355301           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  108D    Montevideo         MG869146           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  72D     Montevideo         MG869143           AMP, S, CT                                                                     \+                \+   \+   \+   \+   \+
  100MA   Corvallis          MG869133           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  97MA    Corvallis          KX355307           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  25B     Corvallis          MG869139           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  95D     Corvallis          MG869134           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  94MA    Corvallis          MG869144           AMP, CT                                                                        \+                \+   \+   \+   \+   \+
  18B     Corvallis          MG869137           AMP, CT                                                                        \+                \+   \+   \+   \+   \+
  19MA    Corvallis          MG869138           AMP, AML, SMX, SSS                                                             \+                \+   \+   \+   \+   \+
  113MA   Corvallis          KX355309           AMP, S, AML, CXM,                                                              \+                \+   \+   \+   \+   \+
  130 D   Saintpaul          KX355311           AMP, S, CT, SMX, SSS, SXT                                                      \+                \+   \+   \+   \+   \+
  104D    Kentucky           MG869145           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  143D    Kentucky           MG869135           AMP, S                                                                         \+                \+   \+   \+   \+   \+
  30D     Kentucky           KX355302           AMP, S, TE, ENR, OFX, CIP, NA, UB                                              \+                \+   \+   \+   \+   \+
  116B    Kentucky           KX355310           AMP, AML, MA, SMX, NA, ENR, UB, OFX, CIP, TE, S, SSS                           \+                \+   \+   \+   \+   \+
  1D      Kentucky           MG869130           AMP, AML, AMC, SMX, NA, ENR, UB, OFX, CIP, TE, S, SSS                          \+                \+   \+   \+   \+   \+
  14D     Kentucky           KX355300           AMP, AML, AMC, MA, SMX, NA, ENR, UB, OFX, CIP, TE, S, SSS                      \+                \+   \+   \+   \+   \+
  102D    Typhimurium        MG869132           AMP, AML, AMC, CRO, MA, CXM, CTX, SXT, SMX, K, AK, CT, TE, S, C, SSS           \+                \+   \+   \+   \+   \+
  105D    Typhimurium        KX355308           AMP, AML, AMC, CRO, MA, CXM, CTX, SXT, SMX, NA, UB, K, AK, CT, TE, S, C, SSS   \+                \+   \+   \+   \+   \+
